|
1
|
Zaino R, Whitney C, Brady MF, DeGeest K,
Burger RA and Buller RE: Simultaneously detected endometrial and
ovarian carcinomas-a prospective clinicopathologic study of 74
cases: A gynecologic oncology group study. Gynecol Oncol.
83:355–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matias-Guiu X and Stewart CJR:
Endometriosis-associated ovarian neoplasia. Pathology. 50:190–204.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ulbright TM and Roth LM: Metastatic and
independent cancers of the endometrium and ovary: A
clinicopathologic study of 34 cases. Hum Pathol. 16:28–34. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scully RE, Young RH and Philip B: Clement
MD: Tumors of the ovary, maldeveloped gonads, Fallopian tube and
broad ligament: Atlas of tumor pahology (AFIP, Atlas of tumor
pathology, No. 23). American registry of pathology. (Washington,
DC). 1999.
|
|
5
|
Schultheis AM, Ng CK, De Filippo MR,
Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS,
Viale A, et al: Massively parallel sequencing-based clonality
analysis of synchronous endometrioid endometrial and ovarian
carcinomas. J Natl Cancer Inst. 108:djv4272016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anglesio MS, Wang YK, Maassen M, Horlings
HM, Bashashati A, Senz J, Mackenzie R, Grewal DS, Li-Chang H,
Karnezis AN, et al: Synchronous endometrial and ovarian carcinomas:
Evidence of clonality. J Natl Cancer Inst. 108:djv4282016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chao A, Wu RC, Jung SM, Lee YS, Chen SJ,
Lu YL, Tsai CL, Lin CY, Tang YH, Chen MY, et al: Implication of
genomic characterization in synchronous endometrial and ovarian
cancers of endometrioid histology. Gynecol Oncol. 143:60–67. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Zhang L, Huang Q, Liu C, Qi L, Li
L, Qu T, Wang Y, Liu S, Meng B, et al: Combination of scoring
criteria and whole exome sequencing analysis of synchronous
endometrial and ovarian carcinomas. Int J Gynecol Cancer.
28:704–712. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kurman RJ, Carcangiu LM, Herrington SC and
Young HR: International Agency for Research on Cancer and World
Health Organization: WHO classification of tumours of female
reproductive organs. International Agency for Research on Cancer
(Lyon). 2014.
|
|
10
|
Baker CL, Vaughn CP and Samowitz WS: A
PIK3CA pyrosequencing-based assay that excludes pseudogene
interference. J Mol Diagn. 14:56–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuo K, Machida H, Frimer M, Marcus JZ,
Pejovic T, Roman LD and Wright JD: Prognosis of women with stage I
endometrioid endometrial cancer and synchronous stage I
endometrioid ovarian cancer. Gynecol Oncol. 147:558–564. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Natee J, Kietpeerakool C, Srisomboon J,
Khunamornpong S, Suprasert P, Phongnarisorn C, Cheewakriangkrai C,
Charoenkwan K, Siriaree S and Pantusart A: Clinicopathologic
analysis of women with synchronous primary carcinomas of the
endometrium and ovary: 10- year experience from Chiang Mai
University Hospital. Asian Pac J Cancer Prev. 7:234–238.
2006.PubMed/NCBI
|
|
13
|
Narin MA, Karalok A, Basaran D, Ureyen I,
Turkmen O, Turan T and Tulunay G: Does synchronous endometrioid
endometrial cancer have any prognostic effect on Stage I
endometrioid ovarian cancer? Eur J Obstet Gynecol Reprod Biol.
200:113–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim YK, Padma R, Foo L, Chia YN, Yam P,
Chia J, Khoo-Tan H, Yap SP and Yeo R: Survival outcome of women
with synchronous cancers of endometrium and ovary: A 10 year
retrospective cohort study. J Gynecol Oncol. 22:239–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dębska-Szmich S, Czernek U, Frąckowiak M,
Frackowiak M, Zięba A, Czyzykowski R, Kulejewska D and Potemski P:
Synchronous primary ovarian and endometrial cancers: A series of
cases and a review of literature. Prz Menopauzalny. 13:64–69.
2014.PubMed/NCBI
|
|
16
|
Eifel P, Hendrickson M, Ross J, Ballon S,
Martinez A and Kempson R: Simultaneous presentation of carcinoma
involving the ovary and the uterine corpus. Cancer. 50:163–170.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karki SC and Chapagain U: Synchronous
primary tumors of the endometrium and ovary. J Pathol Nepal.
2:189–192. 2012. View Article : Google Scholar
|
|
18
|
Liu Y, Li J, Jin H, Lu Y and Lu X:
Clinicopathological characteristics of patients with synchronous
primary endometrial and ovarian cancers: A review of 43 cases.
Oncol Lett. 5:267–270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soliman PT, Slomovitz BM, Broaddus RR, Sun
CC, Oh JC, Eifel PJ, Gershenson DM and Lu KH: Synchronous primary
cancers of the endometrium and ovary: A single institution review
of 84 cases. Gynecol Oncol. 94:456–462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song T, Seong SJ, Bae DS, Suh DH, Kim DY,
Lee KH, Lim MC and Lee TS: Synchronous primary cancers of the
endometrium and ovary in young women: A Korean Gynecologic Oncology
Group Study. Gynecol Oncol. 131:624–628. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sozen H, Vatansever D, Iyibozkurt AC,
Topuz S, Ozsurmeli M, Salihoglu Y, Guzelbey B and Berkman S:
Clinicopathologic and survival analyses of synchronous primary
endometrial and epithelial ovarian cancers. J Obstet Gynaecol Res.
41:1813–1819. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prat J, Matias-Guiu X and Barreto J:
Simultaneous carcinoma involving the endometrium and the ovary. A
clinicopathologic, immunohistochemical, and DNA flow cytometric
study of 18 cases. Cancer. 68:2455–2459. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Halperin R, Zehavi S, Hadas E, Habler L,
Bukovsky I and Schneider D: Simultaneous carcinoma of the
endometrium and ovary vs endometrial carcinoma with ovarian
metastases: A clinical and immunohistochemical determination. Int J
Gynecol Cancer. 13:32–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Desouki MM, Kallas SJ, Khabele D, Crispens
MA, Hameed O and Fadare O: Differential vimentin expression in
ovarian and uterine corpus endometrioid adenocarcinomas: Diagnostic
utility in distinguishing double primaries from metastatic tumors.
Int J Gynecol Pathol. 33:274–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujii H, Matsumoto T, Yoshida M, Furugen
Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N,
et al: Genetics of synchronous uterine and ovarian endometrioid
carcinoma: Combined analyses of loss of heterozygosity, PTEN
mutation and microsatellite instability. Hum Pathol. 33:421–428.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moreno-Bueno G, Gamallo C, Pérez-Gallego
L, de Mora JC, Suárez A and Palacios J: Beta-catenin expression
pattern, beta-catenin gene mutations, and microsatellite
instability in endometrioid ovarian carcinomas and synchronous
endometrial carcinomas. Diagn Mol Pathol. 10:116–122. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kobayashi Y, Nakamura K, Nomura H, Banno
K, Irie H, Adachi M, Iida M, Umene K, Nogami Y, Masuda K, et al:
Clinicopathologic analysis with immunohistochemistry for DNA
mismatch repair protein expression in synchronous primary
endometrial and ovarian cancers. Int J Gynecol Cancer. 25:440–446.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emmert-Buck MR, Chuaqui R, Zhuang Z,
Nogales F, Liotta LA and Merino MJ: Molecular analysis of
synchronous uterine and ovarian endometrioid tumors. Int J Gynecol
Pathol. 16:143–148. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujita M, Enomoto T, Wada H, Inoue M,
Okudaira Y and Shroyer KR: Application of clonal analysis.
Differential diagnosis for synchronous primary ovarian and
endometrial cancers and metastatic cancer. Am J Clin Pathol.
105:350–359. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Irving JA, Catasús L, Gallardo A,
Bussaglia E, Romero M, Matias-Guiu X and Prat J: Synchronous
endometrioid carcinomas of the uterine corpus and ovary:
Alterations in the beta-catenin (CTNNB1) pathway are associated
with independent primary tumors and favorable prognosis. Hum
Pathol. 36:605–619. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin WM, Forgacs E, Warshal DP, Yeh IT,
Martin JS, Ashfaq R and Muller CY: Loss of heterozygosity and
mutational analysis of the PTEN/MMAC1 gene in synchronous
endometrial and ovarian carcinomas. Clin Cancer Res. 4:2577–2583.
1998.PubMed/NCBI
|
|
32
|
Matias-Guiu X, Bussaglia E, Catasus L,
Lagarda H, Gras E, Machin P, Prat J; Correspondence re: W.M. Lin, ;
et al: loss of heterozygosity and mutational analysis of the
PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Clin. Cancer Res. 4:2577–2583. 1998.Clin Cancer Res 6: 1598-1600,
2000. PubMed/NCBI
|
|
33
|
Nishimura N, Hachisuga T, Nabeshima K and
Kawarabayashi T: Synchronous endometrial and ovarian carcinomas:
Analysis of genetic relationship of the tumors. Int J Oncol.
27:1519–1526. 2005.PubMed/NCBI
|
|
34
|
Ricci R, Komminoth P, Bannwart F, Torhorst
J, Wight E, Heitz PU and Caduff RF: PTEN as a molecular marker to
distinguish metastatic from primary synchronous endometrioid
carcinomas of the ovary and uterus. Diagn Mol Pathol. 12:71–78.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shenson DL, Gallion HH, Powell DE and
Pieretti M: Loss of heterozygosity and genomic instability in
synchronous endometrioid tumors of the ovary and endometrium.
Cancer. 76:650–657. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kelemen LE, Rambau PF, Koziak JM, Steed H
and Köbel M: Synchronous endometrial and ovarian carcinomas:
Predictors of risk and associations with survival and tumor
expression profiles. Cancer Causes Control. 28:447–457. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ratajska M, Antoszewska E, Piskorz A,
Brozek I, Borg Å, Kusmierek H, Biernat W and Limon J: Cancer
predisposing BARD1 mutations in breast-ovarian cancer families.
Breast Cancer Res Treat. 131:89–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hamel N, Feng BJ, Foretova L,
Stoppa-Lyonnet D, Narod SA, Imyanitov E, Sinilnikova O, Tihomirova
L, Lubinski J, Gronwald J, et al: On the origin and diffusion of
BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum
Genet. 19:300–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pohlreich P, Zikan M, Stribrna J, Kleibl
Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo
C and Matous B: High proportion of recurrent germline mutations in
the BRCA1 gene in breast and ovarian cancer patients from the
Prague area. Breast Cancer Res. 7:R728–R736. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cerami E, Gao JJ, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Němejcová K, Tichá I, Kleiblová P, Bártů
M, Cibula D, Jirsová K and Dundr P: Expression, epigenetic and
genetic changes of HNF1B in endometrial lesions. Pathol Oncol Res.
22:523–530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu RC, Veras E, Lin J, Gerry E,
Bahadirli-Talbott A, Baras A, Ayhan A, Shih IM and Wang TL:
Elucidating the pathogenesis of synchronous and metachronous tumors
in a woman with endometrioid carcinomas using a whole-exome
sequencing approach. Cold Spring Harb Mol Case Stud. 3(pii):
a0016932017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Valtcheva N, Lang FM, Noske A, Samartzis
EP, Schmidt AM, Bellini E, Fink D, Moch H, Rechsteiner M, Dedes KJ
and Wild PJ: Tracking the origin of simultaneous endometrial and
ovarian cancer by next-generation sequencing-a case report. BMC
Cancer. 17:662017. View Article : Google Scholar : PubMed/NCBI
|
